Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein binding involved in heterotypic cell-cell adhesion	CD200R1L DSP CD200R1 CXADR	2.84e-05	18	203	4	GO:0086080
GeneOntologyMolecularFunction	DNA helicase activity	DHX36 BRIP1 ERCC3 RECQL5 NAV2 XRCC6	3.92e-05	62	203	6	GO:0003678
GeneOntologyMolecularFunction	protein tyrosine kinase activity	EPHB4 PDGFRA MATK NEK1 BMX CLK3 WEE1 HCK	1.20e-04	145	203	8	GO:0004713
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO1 NOMO3	7.37e-05	9	204	3	GO:0160064
MousePheno	increased adenocarcinoma incidence	BRIP1 EAF2 ATAD5 KRAS GPRC5A YY1AP1 HCK TP73	2.92e-05	103	165	8	MP:0009308
MousePheno	increased lung adenocarcinoma incidence	EAF2 ATAD5 KRAS GPRC5A HCK TP73	4.44e-05	55	165	6	MP:0002027
MousePheno	increased lung non-small cell carcinoma incidence	EAF2 ATAD5 KRAS GPRC5A HCK TP73	4.44e-05	55	165	6	MP:0008716
Domain	DUF2012	NOMO2 NOMO1 NOMO3	5.10e-06	4	204	3	PF09430
Domain	DUF2012	NOMO2 NOMO1 NOMO3	5.10e-06	4	204	3	IPR019008
Domain	FerI	DYSF OTOF MYOF	1.26e-05	5	204	3	SM01202
Domain	FerB	DYSF OTOF MYOF	1.26e-05	5	204	3	SM01201
Domain	Ferlin_B-domain	DYSF OTOF MYOF	1.26e-05	5	204	3	IPR012561
Domain	Ferlin_C	DYSF OTOF MYOF	1.26e-05	5	204	3	PF16165
Domain	Ferlin_C	DYSF OTOF MYOF	1.26e-05	5	204	3	IPR032362
Domain	FerIin_dom	DYSF OTOF MYOF	1.26e-05	5	204	3	IPR012968
Domain	FerI	DYSF OTOF MYOF	1.26e-05	5	204	3	PF08151
Domain	FerB	DYSF OTOF MYOF	1.26e-05	5	204	3	PF08150
Domain	Carb-bd-like_fold	NOMO2 NOMO1 NOMO3	6.91e-05	8	204	3	IPR013784
Domain	Tscrpt_elong_fac_Eaf_N	EAF2 EAF1	1.19e-04	2	204	2	IPR019194
Domain	EAF	EAF2 EAF1	1.19e-04	2	204	2	PF09816
Domain	EAF_fam	EAF2 EAF1	1.19e-04	2	204	2	IPR027093
Domain	CarboxyPept_regulatory_dom	NOMO2 NOMO1 NOMO3	3.39e-04	13	204	3	IPR014766
Domain	-	NOMO2 NOMO1 NOMO3	3.39e-04	13	204	3	2.60.40.1120
Domain	FerA	DYSF MYOF	3.54e-04	3	204	2	SM01200
Domain	Ferlin_A-domain	DYSF MYOF	3.54e-04	3	204	2	IPR012560
Domain	FerA	DYSF MYOF	3.54e-04	3	204	2	PF08165
Domain	PTCB-BRCT	TOPBP1 PAXIP1	7.02e-04	4	204	2	PF12738
Domain	DysFC	DYSF MYOF	7.02e-04	4	204	2	SM00694
Domain	DysFN	DYSF MYOF	7.02e-04	4	204	2	SM00693
Domain	Peroxin/Ferlin	DYSF MYOF	7.02e-04	4	204	2	IPR006614
Domain	CarboxyPept-like_regulatory	NOMO2 NOMO1 NOMO3	7.80e-04	17	204	3	IPR008969
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PDGFRA DOCK11 MAPT MATK SIPA1L3 NEK1 BMX CLK3 PI4KA SVIL NAV2 PPIP5K2 DSP WEE1 KIF26B EPB41L5 DENND4C PPP4R4 ARHGEF10 USP54 ARHGEF4 DCLK1 EPB41L1	2.33e-09	861	207	23	36931259
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	MRPS31 TRAF2 TTLL3 SVIL MAPKAPK3 KRAS DSP WEE1 ADNP SCYL2 P4HB MOB1A CAPRIN1 XRCC6	1.52e-07	401	207	14	25852190
Pubmed	FerA is a Membrane-Associating Four-Helix Bundle Domain in the Ferlin Family of Membrane-Fusion Proteins.	DYSF OTOF MYOF	2.08e-07	3	207	3	30026467
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO1 NOMO3	2.08e-07	3	207	3	36011023
Pubmed	The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers.	DYSF OTOF MYOF	2.08e-07	3	207	3	23859474
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO1 NOMO3	2.08e-07	3	207	3	25576386
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYT1L CFH TRAF2 MYO1E PPRC1 ENPP2 SIPA1L3 IFIT5 CRNKL1 OTOF NOMO2 RETREG1 WASHC4 ADAMTS1 DSP ZNFX1 GRIN2B SCYL2 NPRL2 ARHGEF10 YY1AP1 USP54 CAPRIN1 DCLK1 XRCC6	2.23e-07	1285	207	25	35914814
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ERCC3 ATAD5 IFIT5 ZNF362 PHF2 KAT2B PI4KA GLYR1 RECQL5 ARID4A POLR2A TOPBP1 DENND4C ARRB2 PAXIP1 XRCC6 RPAP2	3.81e-07	645	207	17	25281560
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DHX36 MYO1E MAPT SIPA1L3 TOMM70 NWD2 PLPPR4 PI4KA SVIL RPS4Y2 LRCH2 DSP DOCK8 FARSB ZNFX1 GRIN2B AFAP1 P4HB IGHG1 OTUD4 USP54 ARHGEF4 CAPRIN1 HCK DCLK1 EPB41L1	4.62e-07	1431	207	26	37142655
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	SIPA1L3 PICALM NEK1 MYPN ANKRD28 LRCH2 KIF26B DENND4C AFAP1 CAPRIN1	5.66e-07	209	207	10	36779422
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	EPHB4 TRAF2 ERCC3 PICALM NEK1 NOMO2 CLK3 WASHC4 WEE1 ADNP DARS2 NOMO1 MYOF MOB1B CNGB3 MOB1A PRKD1 EIF3B HCK NOMO3	6.16e-07	910	207	20	36736316
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO1 NOMO3	8.28e-07	4	207	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO1 NOMO3	8.28e-07	4	207	3	9267806
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ATAD5 SIPA1L3 ZNF362 BLMH PHF2 TOMM70 PI4KA GLYR1 SVIL ANKRD28 STX17 HSDL2 DSP POLR2A FCHO2 PPP4R4 P4HB MOB1A OTUD4 EPB41L1 CXADR	1.42e-06	1049	207	21	27880917
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DOCK11 SIPA1L3 PICALM PLPPR4 PI4KA SVIL ANKRD28 KRAS CACNA1E LRCH2 FARSB ZNFX1 GRIN2B ADNP OTUD4 PRKD1 CAPRIN1 DCLK1 XRCC6 EPB41L1	1.47e-06	963	207	20	28671696
Pubmed	A protein interaction landscape of breast cancer.	BRIP1 SIPA1L3 PFKFB4 PICALM TOMM70 PI4KA SVIL NAV2 ANKRD28 CUL2 POLR2A FARSB IGHG1 XRCC6 EPB41L1 RPAP2	1.49e-06	634	207	16	34591612
Pubmed	Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain.	KRAS ABCC9 GRIN2B	2.06e-06	5	207	3	9514948
Pubmed	Genome-wide ENU mutagenesis in combination with high density SNP analysis and exome sequencing provides rapid identification of novel mouse models of developmental disease.	IFT140 FRAS1 CRKL	2.06e-06	5	207	3	23469164
Pubmed	The BRCT domain is a phospho-protein binding domain.	BRIP1 POLR2A TOPBP1	4.10e-06	6	207	3	14576433
Pubmed	BRCT repeats as phosphopeptide-binding modules involved in protein targeting.	BRIP1 TOPBP1 PAXIP1	4.10e-06	6	207	3	14576432
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BRIP1 CYP2C18 MAPT MATK TBC1D2 SVIL ARID4A DSP WEE1 POLR2A MYOF EIF2D OTUD4 YY1AP1 EIF3B XRCC6 CXADR	4.48e-06	774	207	17	15302935
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MRPS31 DHX36 TRAF2 BLMH PHF2 S100A8 TOMM70 CRNKL1 PI4KA GLYR1 DNAH5 HSDL2 DSP POLR2A FARSB ADNP DARS2 CRKL NOMO1 P4HB EIF3B GALNT5 CAPRIN1 XRCC6	4.84e-06	1425	207	24	30948266
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	TBC1D2 IFIT5 MYSM1 MEX3A GLYR1 SVIL UGCG DNAH5 MYOF ARHGEF10 EIF3B	5.53e-06	332	207	11	37433992
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DHX36 TRAF2 ERCC3 BLMH S100A8 CRNKL1 PI4KA GLYR1 RECQL5 ANKRD28 WASHC4 DSP POLR2A EPB41L5 FARSB ADNP EIF2D ARRB2 P4HB IGHG1 EIF3B CAPRIN1 XRCC6	6.67e-06	1353	207	23	29467282
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PPRC1 TOMM70 ADGRL3 FRAS1 LRCH2 VPS8 HEATR5A OTUD4 YY1AP1 ARHGEF4 EPB41L1 SENP7	6.76e-06	407	207	12	12693553
Pubmed	Germinal center B-cells resist transformation by Kras independently of tumor suppressor Arf.	KRAS IGHG1 IGHG3	7.15e-06	7	207	3	23825691
Pubmed	GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer.	DHX36 GLYR1 SVIL DSP EPB41L5 SCYL2 OTUD4 CAPRIN1 XRCC6	8.39e-06	223	207	9	33731348
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYT1L SIPA1L3 PHF2 NAV2 ANKRD28 MYOF ARHGEF10 ARHGEF4 UNC80	9.01e-06	225	207	9	12168954
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	SIPA1L3 PICALM ANKRD28 LRCH2 DOCK8 FCHO2 P4HB	1.05e-05	125	207	7	29467281
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MRPS31 ERCC3 ATAD5 SIPA1L3 PHF2 TOMM70 CRNKL1 CLK3 PI4KA RECQL5 POLR2A TOPBP1 EPB41L5 FARSB E4F1 SIRT7 NOMO1 MYOF AFAP1 P4HB OTUD4 EIF3B DCLK1 EPB41L1	1.10e-05	1497	207	24	31527615
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO2 NOMO1 NOMO3	1.14e-05	8	207	3	15257293
Pubmed	Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.	POLR2A IGHG1 IGHG3	1.14e-05	8	207	3	22431510
Pubmed	TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.	TRAF2 IGHG1 IGHG3	1.14e-05	8	207	3	32591397
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	IFT140 TRAF2 ATP7B MAPT ATAD5 ZNF362 PHF2 KAT2B ANKRD28 ADAMTS1 WEE1 POLR2A EAF1 TIMM21 CLMP USP54 UNC80 SENP7 TP73 RPAP2	1.30e-05	1116	207	20	31753913
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	BTBD6 S100A8 RECQL5 ANKRD28 WEE1 POLR2A NOMO1 BTBD16 ANKRD44 PAXIP1 EIF3B XRCC6 NOMO3 TP73 RPAP2	1.33e-05	670	207	15	22990118
Pubmed	Human transcription factor protein interaction networks.	MRPS31 DHX36 ATAD5 PHF2 S100A8 KAT2B GLYR1 RECQL5 SVIL ANKRD28 CUL2 ARID4A ADNP ZBTB14 ZFPM2 P4HB PAXIP1 OTUD4 YY1AP1 EIF3B USP54 CAPRIN1 XRCC6	1.59e-05	1429	207	23	35140242
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO2 NOMO1 NOMO3	1.70e-05	9	207	3	36261522
Pubmed	Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.	MASP1 PKDREJ S100A8 CLK3 FCHO2 PPP4R4 TIMM21 SERAC1 EIF3B	2.51e-05	256	207	9	24189400
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO2 NOMO1 NOMO3	3.31e-05	11	207	3	32820719
Pubmed	RECQ5 helicase associates with the C-terminal repeat domain of RNA polymerase II during productive elongation phase of transcription.	RECQL5 POLR2A	3.53e-05	2	207	2	20705653
Pubmed	Ferlin Overview: From Membrane to Cancer Biology.	OTOF MYOF	3.53e-05	2	207	2	31443490
Pubmed	Regulation of p73 by Hck through kinase-dependent and independent mechanisms.	HCK TP73	3.53e-05	2	207	2	17535448
Pubmed	Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.	BRIP1 TOPBP1	3.53e-05	2	207	2	21127055
Pubmed	Defective FESTA/EAF2-mediated transcriptional activation in S-II-deficient embryonic stem cells.	EAF2 POLR2A	3.53e-05	2	207	2	17892859
Pubmed	TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.	ANOS1 TP73	3.53e-05	2	207	2	29222041
Pubmed	Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification.	KRAS POLR2A	3.53e-05	2	207	2	25144301
Pubmed	Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts.	KRAS POLR2A	3.53e-05	2	207	2	25217522
Pubmed	Association of human DNA helicase RecQ5beta with RNA polymerase II and its possible role in transcription.	RECQL5 POLR2A	3.53e-05	2	207	2	18419580
Pubmed	ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.	EAF2 EAF1	3.53e-05	2	207	2	16114057
Pubmed	Crystal structure of autotaxin and insight into GPCR activation by lipid mediators.	ENPP1 ENPP2	3.53e-05	2	207	2	21240269
Pubmed	p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.	KAT2B TP73	3.53e-05	2	207	2	17611664
Pubmed	Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice.	CD200R1L CD200R1	3.53e-05	2	207	2	23097187
Pubmed	Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.	MAPT PICALM	3.53e-05	2	207	2	23589030
Pubmed	CD200R1 Contributes to Successful Functional Reinnervation after a Sciatic Nerve Injury.	CD200R1L CD200R1	3.53e-05	2	207	2	35681481
Pubmed	CD200R1 regulates eosinophilia during pulmonary fungal infection in mice.	CD200R1L CD200R1	3.53e-05	2	207	2	31365119
Pubmed	Depletion of MOB1A/B causes intestinal epithelial degeneration by suppressing Wnt activity and activating BMP/TGF-β signaling.	MOB1B MOB1A	3.53e-05	2	207	2	30349003
Pubmed	CD200 receptor and macrophage function in the intestine.	CD200R1L CD200R1	3.53e-05	2	207	2	22204814
Pubmed	Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200.	CD200R1L CD200R1	3.53e-05	2	207	2	17667818
Pubmed	Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b.	DYSF MYOF	3.53e-05	2	207	2	18495154
Pubmed	NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease.	CYBB KRAS	3.53e-05	2	207	2	30323311
Pubmed	The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.	CD200R1L CD200R1	3.53e-05	2	207	2	33823877
Pubmed	Human Mob1 proteins are required for cytokinesis by controlling microtubule stability.	MOB1B MOB1A	3.53e-05	2	207	2	22454515
Pubmed	MicroRNA-129-5p-regulated microglial expression of the surface receptor CD200R1 controls neuroinflammation.	CD200R1L CD200R1	3.53e-05	2	207	2	34952004
Pubmed	ELL-associated factors EAF1/2 negatively regulate HIV-1 transcription through inhibition of Super Elongation Complex formation.	EAF2 EAF1	3.53e-05	2	207	2	32087315
Pubmed	Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains.	DYSF MYOF	3.53e-05	2	207	2	11959863
Pubmed	PICALM modulates autophagy activity and tau accumulation.	MAPT PICALM	3.53e-05	2	207	2	25241929
Pubmed	Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle.	DYSF MYOF	3.53e-05	2	207	2	34354129
Pubmed	Demonstration of IgG Subclass (IgG1 and IgG3) in Immuno-Related Hemocytopenia.	IGHG1 IGHG3	3.53e-05	2	207	2	29945307
Pubmed	Involvement of protein kinase D in expression and trafficking of ATP7B (copper ATPase).	ATP7B PRKD1	3.53e-05	2	207	2	21189263
Pubmed	CD200-CD200R1 inhibitory signaling prevents spontaneous bacterial infection and promotes resolution of neuroinflammation and recovery after stroke.	CD200R1L CD200R1	3.53e-05	2	207	2	30777093
Pubmed	Ligation of CD200R by CD200 is not required for normal murine myelopoiesis.	CD200R1L CD200R1	3.53e-05	2	207	2	17803680
Pubmed	A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.	CD200R1L CD200R1	3.53e-05	2	207	2	27385779
Pubmed	Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.	KRAS WEE1	3.53e-05	2	207	2	29343688
Pubmed	Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP.	CLMP CXADR	3.53e-05	2	207	2	17538635
Pubmed	CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization.	CD200R1L CD200R1	3.53e-05	2	207	2	24170042
Pubmed	Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.	PFKFB4 BMX	3.53e-05	2	207	2	29208667
Pubmed	A regulatory circuit comprising the CBP and SIRT7 regulates FAM134B-mediated ER-phagy.	RETREG1 SIRT7	3.53e-05	2	207	2	37043189
Pubmed	Association between Gm allotypes and asthma severity from childhood to young middle age.	IGHG1 IGHG3	3.53e-05	2	207	2	17933503
Pubmed	The CD200 receptor is a novel and potent regulator of murine and human mast cell function.	CD200R1L CD200R1	3.53e-05	2	207	2	15661892
Pubmed	Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies.	MAPT ADNP	3.53e-05	2	207	2	34865853
Pubmed	Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.	MOB1B MOB1A	3.53e-05	2	207	2	23143302
Pubmed	Structural Basis for the Distinct Membrane Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin.	DYSF MYOF	3.53e-05	2	207	2	31004665
Pubmed	A role for altered TLR gene expression in association with increased expression of CD200R in the induction of mucosal tissue CD4(+) Treg in aged mice following gavage with a liver extract along with intramuscular monophosphoryl lipid A (MPLA) injection.	CD200R1L CD200R1	3.53e-05	2	207	2	18555631
Pubmed	Immunoglobulin GM genes as functional risk and protective factors for the development of Alzheimer's disease.	IGHG1 IGHG3	3.53e-05	2	207	2	19542624
Pubmed	While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems.	DYSF MYOF	3.53e-05	2	207	2	19228595
Pubmed	TRAF2 associates with cullin neddylation complex assembly.	TRAF2 CUL2	3.53e-05	2	207	2	38978293
Pubmed	Characterization of human cd200 glycoprotein receptor gene located on chromosome 3q12-13.	CD200R1L CD200R1	3.53e-05	2	207	2	12853143
Pubmed	CD200R deletion promotes a neutrophil niche for Francisella tularensis and increases infectious burden and mortality.	CD200R1L CD200R1	3.53e-05	2	207	2	31073183
Pubmed	Candidate genes for congenital diaphragmatic hernia from animal models: sequencing of FOG2 and PDGFRalpha reveals rare variants in diaphragmatic hernia patients.	PDGFRA ZFPM2	3.53e-05	2	207	2	17568391
Pubmed	Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.	KRAS POLR2A	3.53e-05	2	207	2	24367082
Pubmed	The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer.	KRAS WEE1	3.53e-05	2	207	2	34688654
Pubmed	Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.	EAF2 EAF1	3.53e-05	2	207	2	31229879
Pubmed	Genetically engineered fusion of MAP-1 and factor H domains 1-5 generates a potent dual upstream inhibitor of both the lectin and alternative complement pathways.	CFH MASP1	3.53e-05	2	207	2	26260032
Pubmed	Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.	ENPP1 ENPP2	3.53e-05	2	207	2	15096095
Pubmed	The SET2-RPB1 interaction domain of human RECQ5 is important for transcription-associated genome stability.	RECQL5 POLR2A	3.53e-05	2	207	2	21402780
Pubmed	Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions.	KRAS PRKD1	3.53e-05	2	207	2	26947075
Pubmed	DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.	MYO1E SVIL DSP AFAP1 XRCC6	3.78e-05	63	207	5	37052853
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	BRIP1 ATAD5 BLMH S100A8 RECQL5 SVIL DSP POLR2A TOPBP1 ADNP P4HB IGHG1 IGHG3 XRCC6	4.07e-05	652	207	14	31180492
Pubmed	Role of Tat protein in HIV neuropathogenesis.	KAT2B CCR3 POLR2A GRIN2B	4.36e-05	33	207	4	19526283
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MRPS31 IFT140 MYO1E NEK1 ASAP2 ANKRD28 PPIP5K2 CUL2 LRCH2 HSDL2 WEE1 DENND4C DARS2 NOMO1 SCYL2 EFHC2 EAF1 P4HB PRKD1 LUM DCLK1	4.54e-05	1321	207	21	27173435
Cytoband	3p21.3	MAPKAPK3 CCR3 TMEM115 NPRL2	1.53e-04	59	208	4	3p21.3
Cytoband	12p12.1	PYROXD1 KRAS ABCC9	3.07e-04	29	208	3	12p12.1
GeneFamily	Ferlin family	DYSF OTOF MYOF	1.26e-05	6	157	3	828
GeneFamily	DNA helicases	BRIP1 ERCC3 XRCC6	3.99e-04	17	157	3	1167
GeneFamily	Ankyrin repeat domain containing\|BRCA1 B complex	BRIP1 TOPBP1	4.44e-04	4	157	2	1335
GeneFamily	Protein phosphatase 6 regulatory subunits	ANKRD28 ANKRD44	1.10e-03	6	157	2	699
GeneFamily	MOB kinase activators\|STRIPAK complex	MOB1B MOB1A	1.53e-03	7	157	2	647
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DOCK11 BMX ASAP2 APBB1IP AFAP1 PRKD1 ARHGEF4	2.17e-03	206	157	7	682
Coexpression	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	CFH PDGFRA ENPP2 CCN4 C7 ADAMTS1 FCHO2 ARHGEF10 CLMP LUM DCLK1	1.02e-06	211	207	11	M12225
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000	CFH PDGFRA DOCK11 CCN4 NEK1 SVIL ADAMTS15 ADGRL3 LRCH2 HSDL2 FCHO2 HCK SENP7	4.60e-06	288	204	13	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	CFH PDGFRA ENPP1 ENPP2 BMP1 CTPS2 NAV2 STX17 ADGRL3 LRCH2 DENND4C ZFPM2 PPP4R4 SCYL2 MYOF CLMP PRKD1 LUM ZMAT1 DCLK1	3.23e-05	740	204	20	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CFH PDGFRA CCN4 MRC2 C7 KIF26B AFAP1 CLMP PRKD1 LUM CFAP69 DCLK1	1.66e-10	197	208	12	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDGFRA MRC2 ADAMTS15 C7 ADAMTS1 KIF26B MYOF AFAP1 CLMP PRKD1 LUM HAS2	1.98e-10	200	208	12	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	CFH MRC2 ADAMTS15 NAV2 C7 GPRC5A CLMP PRKD1 LUM HAS2 DCLK1	1.00e-09	181	208	11	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	1.58e-09	189	208	11	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	1.58e-09	189	208	11	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA ENPP1 CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	1.76e-09	191	208	11	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	1.76e-09	191	208	11	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	1.76e-09	191	208	11	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA ENPP1 CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	1.76e-09	191	208	11	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	1.86e-09	192	208	11	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRC2 ADAMTS15 C7 KIF26B MYOF AFAP1 CLMP PRKD1 LUM HAS2 CFAP69	2.08e-09	194	208	11	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	2.08e-09	194	208	11	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	2.08e-09	194	208	11	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ADAMTS1 ABCC9 ZFPM2 CLMP LUM DCLK1	2.32e-09	196	208	11	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ADAMTS1 ABCC9 ZFPM2 CLMP LUM DCLK1	2.32e-09	196	208	11	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	CFH MRC2 ADAMTS15 NAV2 C7 GPRC5A ANKRD44 CLMP PRKD1 HAS2 DCLK1	2.32e-09	196	208	11	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ADAMTS1 ABCC9 ZFPM2 CLMP LUM DCLK1	2.44e-09	197	208	11	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MYT1L CFH PDGFRA CCN4 NAV2 C7 ADAMTS1 LUM HAS2 DCLK1 ZNF287	2.44e-09	197	208	11	31c8d6e565bbdc37843ce871fe91845b0cc18a9f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ADGRL3 ADAMTS1 ABCC9 ZFPM2 CLMP DCLK1	2.58e-09	198	208	11	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CFH PDGFRA CCN4 MRC2 NAV2 C7 FRAS1 KIF26B CLMP PRKD1 LUM	2.58e-09	198	208	11	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFRA CCN4 MRC2 ADAMTS15 C7 ADAMTS1 MYOF AFAP1 CLMP LUM HAS2	2.72e-09	199	208	11	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	medial-mesenchymal-Alveolar_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH PDGFRA CCN4 MRC2 NAV2 C7 FRAS1 ADAMTS1 CLMP LUM HAS2	2.86e-09	200	208	11	c22cbfecee00183dd4be678f116ab9fd9ad0a4dd
ToppCell	medial-2-mesenchymal-Alveolar_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH PDGFRA CCN4 MRC2 NAV2 C7 FRAS1 ADAMTS1 CLMP LUM HAS2	2.86e-09	200	208	11	cc6062dac07916c29091fc6bee2b864d29e6525b
ToppCell	medial-mesenchymal-Alveolar_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH PDGFRA CCN4 MRC2 NAV2 C7 FRAS1 ADAMTS1 CLMP LUM HAS2	2.86e-09	200	208	11	5c0716bf375c8158f7dc2c82bf5eaf37af594dd0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CCN4 MRC2 NAV2 C7 ADAMTS1 ABCC9 ZFPM2 ZNF705G CLMP	1.24e-08	178	208	10	d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANOS1 NAV2 FRAS1 DSP EPB41L5 HEATR5A GPRC5A MYOF GALNT5 CXADR	1.31e-08	179	208	10	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANOS1 NAV2 FRAS1 DSP EPB41L5 HEATR5A GPRC5A MYOF GALNT5 CXADR	1.46e-08	181	208	10	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRAF2 ZNF585B CCN4 PLPPR4 MRC2 ADGRL3 LRCH2 ADAMTS1 PAXIP1 CLMP	1.62e-08	183	208	10	5377b4fbd8fdfe68933b4c0965aa9525f7f31591
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	CFH PDGFRA NAV2 C7 ABCC9 ZFPM2 CLMP LUM CFAP69 DCLK1	1.80e-08	185	208	10	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH PDGFRA CCN4 PLPPR4 MRC2 C7 ADAMTS1 CLMP LUM HAS2	1.89e-08	186	208	10	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANOS1 NAV2 FRAS1 DSP EPB41L5 GPRC5A MYOF USP54 GALNT5 CXADR	1.89e-08	186	208	10	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SIPA1L3 ANOS1 NAV2 FRAS1 DSP EPB41L5 GPRC5A USP54 GALNT5 CXADR	1.99e-08	187	208	10	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA ENPP1 CCN4 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	2.56e-08	192	208	10	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCN4 C7 KIF26B MYOF AFAP1 CLMP PRKD1 LUM HAS2 CFAP69	2.56e-08	192	208	10	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA ENPP1 CCN4 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	2.56e-08	192	208	10	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	CFH MYO1E ENPP2 BMX NOMO2 MRC2 ADAMTS1 NOMO1 MYOF NOMO3	2.56e-08	192	208	10	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ADAMTS1 ABCC9 ZFPM2 CLMP LUM	2.69e-08	193	208	10	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ADAMTS1 ABCC9 ZFPM2 CLMP LUM	2.69e-08	193	208	10	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	2.82e-08	194	208	10	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	2.82e-08	194	208	10	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CFH PDGFRA CCN4 C7 KIF26B ZFPM2 CLMP LUM HAS2 DCLK1	2.82e-08	194	208	10	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CCN4 MRC2 NAV2 C7 ADGRL3 ABCC9 ZFPM2 LUM DCLK1	2.82e-08	194	208	10	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	2.82e-08	194	208	10	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	2.96e-08	195	208	10	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDGFRA ENPP1 ENPP2 CCN4 BMP1 MRC2 FRAS1 CLMP LUM HAS2	3.26e-08	197	208	10	63b63c6b2f842adb87bc83222ff86796bd9b58f6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA ENPP1 CCN4 MRC2 C7 ABCC9 ZFPM2 CLMP LUM	3.26e-08	197	208	10	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA ENPP1 CCN4 MRC2 C7 ABCC9 ZFPM2 CLMP LUM	3.26e-08	197	208	10	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	CFH PDGFRA MRC2 C7 KIF26B ZFPM2 CLMP PRKD1 LUM DCLK1	3.26e-08	197	208	10	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDGFRA ENPP1 ENPP2 CCN4 BMP1 MRC2 FRAS1 CLMP LUM HAS2	3.26e-08	197	208	10	fb50903b87498b400c8e16e6a561b6d9458e5d97
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	CFH PDGFRA CCN4 MRC2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	3.42e-08	198	208	10	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	MYO1E ENPP2 PICALM SVIL UGCG NAV2 ANKRD28 MYOF AFAP1 OTUD4	3.42e-08	198	208	10	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDGFRA MRC2 ADAMTS15 C7 ADAMTS1 MYOF AFAP1 CLMP LUM HAS2	3.59e-08	199	208	10	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFRA CCN4 MRC2 C7 ADAMTS1 MYOF AFAP1 CLMP HAS2 CFAP69	3.59e-08	199	208	10	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	CFH PDGFRA CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM	3.59e-08	199	208	10	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANOS1 NAV2 FRAS1 DSP EPB41L5 HEATR5A MYOF USP54 GALNT5 CXADR	3.59e-08	199	208	10	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	PDGFRA MRC2 ADAMTS15 C7 ADAMTS1 ABCC9 CLMP LUM HAS2 DCLK1	3.76e-08	200	208	10	2c5626ea8fb4b702d4560117e53edf6cfcf1971e
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDGFRA MRC2 ADAMTS15 C7 ADAMTS1 MYOF AFAP1 PRKD1 LUM HAS2	3.76e-08	200	208	10	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDGFRA MRC2 ADAMTS15 C7 ADAMTS1 MYOF AFAP1 PRKD1 LUM HAS2	3.76e-08	200	208	10	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANOS1 NAV2 FRAS1 DSP EPB41L5 HEATR5A MYOF USP54 GALNT5 CXADR	3.76e-08	200	208	10	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	PDGFRA MRC2 ADAMTS15 C7 ADAMTS1 MYOF CLMP PRKD1 LUM HAS2	3.76e-08	200	208	10	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH PDGFRA MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	3.76e-08	200	208	10	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CFH RIN3 MAPT PLPPR4 MRC2 C7 ADAMTS1 PPP4R4 CLMP	7.84e-08	163	208	9	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH BRIP1 CCN4 MRC2 NAV2 C7 ZFPM2 CLMP HAS2	1.07e-07	169	208	9	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANOS1 NAV2 FRAS1 DSP EPB41L5 HEATR5A GPRC5A GALNT5 CXADR	1.59e-07	177	208	9	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CCN4 MRC2 NAV2 C7 ABCC9 ZFPM2 CLMP DCLK1	2.20e-07	184	208	9	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	COVID-19-lung-B_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EAF2 DOCK11 APBB1IP DOCK8 CD200R1 ANKRD44 IGHG1 IGHG3 RASGRP2	2.31e-07	185	208	9	e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANOS1 NAV2 FRAS1 GPRC5A MYOF USP54 GALNT5 DCLK1 CXADR	2.42e-07	186	208	9	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	CCN4 PLPPR4 ADGRL3 LRCH2 ADAMTS1 ABCC9 ZFPM2 MYOF DCLK1	2.42e-07	186	208	9	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Control-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	MYO1E ENPP2 BMP1 UGCG ANKRD28 C7 CA8 MYOF OTUD4	2.53e-07	187	208	9	5429ae85942b8ec3895cceb63c663de3c24ca064
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFH CCN4 BMP1 MRC2 FRAS1 ABCC9 LUM HAS2 DCLK1	2.53e-07	187	208	9	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E CHST9 SVIL UGCG RETREG1 DNAH5 FRAS1 WEE1 EPB41L1	2.77e-07	189	208	9	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E CHST9 SVIL UGCG RETREG1 DNAH5 FRAS1 WEE1 EPB41L1	2.77e-07	189	208	9	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 NAV2 C7 CA8 ABCC9 CLMP LUM	2.77e-07	189	208	9	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA MRC2 C7 KIF26B ABCC9 ZFPM2 CLMP LUM HAS2	2.89e-07	190	208	9	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCN4 MRC2 C7 KIF26B MYOF AFAP1 CLMP HAS2 CFAP69	2.89e-07	190	208	9	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA MRC2 C7 KIF26B ABCC9 ZFPM2 CLMP LUM HAS2	2.89e-07	190	208	9	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH PDGFRA CCN4 PLPPR4 MRC2 C7 CLMP LUM DCLK1	3.02e-07	191	208	9	0fae1c2ef9f83ac7721d0a9d69455bf97eed9257
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SVIL UGCG RETREG1 NAV2 DNAH5 ADAMTS1 MYOF PRKD1	3.02e-07	191	208	9	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 C7 KIF26B ABCC9 ZFPM2 CLMP LUM	3.02e-07	191	208	9	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SVIL UGCG RETREG1 NAV2 DNAH5 ADAMTS1 MYOF PRKD1	3.02e-07	191	208	9	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CCN4 MRC2 C7 ABCC9 ZFPM2 CLMP LUM DCLK1	3.16e-07	192	208	9	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCN4 MRC2 C7 MYOF AFAP1 CLMP LUM HAS2 CFAP69	3.16e-07	192	208	9	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRC2 ADAMTS15 C7 KIF26B MYOF AFAP1 CLMP PRKD1 LUM	3.16e-07	192	208	9	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 C7 CA8 KIF26B ABCC9 CLMP LUM	3.45e-07	194	208	9	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH MAPT UGCG NAV2 C7 GRIN2B ZFPM2 HAS2 DCLK1	3.45e-07	194	208	9	c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57
ToppCell	COPD-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	MYO1E SVIL UGCG ANKRD28 C7 ADAMTS1 MYOF AFAP1 OTUD4	3.45e-07	194	208	9	8dcde77767b23e75360adb316cdccf56a00e3726
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 C7 CA8 KIF26B ABCC9 CLMP LUM	3.45e-07	194	208	9	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	RIN3 DOCK11 TBC1D2 APBB1IP DOCK8 FCHO2 ARRB2 ARHGAP18 HCK	3.45e-07	194	208	9	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ABCC9 ZFPM2 CLMP LUM	3.60e-07	195	208	9	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDGFRA CCN4 MRC2 C7 ABCC9 ZFPM2 CLMP LUM	3.60e-07	195	208	9	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	CFH MRC2 NAV2 C7 ZFPM2 ANKRD44 CLMP PRKD1 DCLK1	3.60e-07	195	208	9	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 C7 CA8 KIF26B ABCC9 CLMP LUM	3.60e-07	195	208	9	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 C7 CA8 KIF26B ABCC9 CLMP LUM	3.60e-07	195	208	9	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDGFRA CCN4 MRC2 ADAMTS15 C7 ZFPM2 CLMP LUM DCLK1	3.76e-07	196	208	9	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	CYBB RIN3 PFKFB4 PICALM S100A8 APBB1IP DOCK8 ARRB2 HCK	3.76e-07	196	208	9	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 C7 CA8 KIF26B ABCC9 CLMP LUM	3.76e-07	196	208	9	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA CCN4 MRC2 C7 CA8 KIF26B ABCC9 CLMP LUM	3.76e-07	196	208	9	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MRC2 C7 ADAMTS1 MYOF AFAP1 CLMP LUM HAS2 CFAP69	3.92e-07	197	208	9	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA MRC2 C7 CA8 KIF26B ABCC9 CLMP LUM HAS2	3.92e-07	197	208	9	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANOS1 NAV2 DNAH5 DSP HEATR5A MYOF USP54 GALNT5 DCLK1	3.92e-07	197	208	9	b94645d57efe8d9e032bffb8c89af1f425c6421e
Drug	Chloroprene	CYBB DHX36 MASP1 RIN3 ATP7B MYO1E ESD COG3 S100A8 CCN4 BMP1 NEK1 BMX MRC2 UGCG ADAMTS15 NAV2 ADGRL3 KRAS GPR18 WASHC4 ADAMTS1 ARID4A WEE1 KIF26B TOPBP1 EPB41L5 DENND4C CD5 MOB1B CLMP HCK	4.79e-07	1348	205	32	ctd:D002737
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	CFH PDGFRA MAPT DIPK1A TBC1D2 PLPPR4 UGCG RETREG1 EPB41L5 EFHC2 CFAP69	7.55e-07	180	205	11	4344_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	PDGFRA DIPK1A ENPP2 ANOS1 PLPPR4 RETREG1 GPRC5A EFHC2 PRKD1 CFAP69 RASGRP2	1.10e-06	187	205	11	6709_UP
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ATAD5 DYSF S100A8 BMP1 GLYR1 ANKRD28 ZBTB14 CRKL ARHGEF4 SENP7	1.05e-05	193	205	10	5629_DN
Drug	PHA-00745360 [351320-33-7]; Up 200; 1uM; MCF7; HT_HG-U133A	KCNMB2 IFT140 MAPT CHRNB2 BMP1 GLYR1 RECQL5 CUL2 ARHGEF4 RASGRP2	1.26e-05	197	205	10	3910_UP
Disease	cell surface glycoprotein CD200 receptor 1 measurement	CFH CD200R1L CD200R1	6.23e-06	6	202	3	EFO_0020253
Disease	pleckstrin homology domain-containing family A member 1 measurement	CFH ZFPM2 BTBD16	1.08e-05	7	202	3	EFO_0802873
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF OTOF MYOF	1.08e-05	7	202	3	DOID:11724 (implicated_via_orthology)
Disease	axin-2 measurement	CFH IGHG1 IGHG3	3.66e-05	10	202	3	EFO_0801400
Disease	disease recurrence, response to allogeneic hematopoietic stem cell transplant	CD200R1L CD200R1	4.66e-05	2	202	2	EFO_0004952, EFO_0007044
Disease	neural cell adhesion molecule 1 measurement	IGHG1 IGHG3	4.66e-05	2	202	2	EFO_0801826
Disease	insulin growth factor-like family member 4 measurement	IGHG1 IGHG3	4.66e-05	2	202	2	EFO_0801701
Disease	myeloid sarcoma (is_implicated_in)	PDGFRA KRAS	4.66e-05	2	202	2	DOID:8683 (is_implicated_in)
Disease	tumor necrosis factor ligand superfamily member 11 measurement	CFH IGHG1 IGHG3	8.59e-05	13	202	3	EFO_0010617
Disease	mannan-binding lectin serine protease 1 measurement	CFH MASP1 NXPE1	1.35e-04	15	202	3	EFO_0008223
Disease	ameloblastin measurement	IGHG1 IGHG3	1.39e-04	3	202	2	EFO_0801377
Disease	paired immunoglobulin-like type 2 receptor alpha measurement	IGHG1 IGHG3	1.39e-04	3	202	2	EFO_0801866
Disease	secretoglobin family 1C member 1 measurement	IGHG1 IGHG3	1.39e-04	3	202	2	EFO_0802041
Disease	glucuronate measurement	CHST9 EPB41L5 DCLK1	2.39e-04	18	202	3	EFO_0010486
Disease	di-N-acetylchitobiase measurement	IGHG1 IGHG3	2.77e-04	4	202	2	EFO_0801524
Disease	beta-defensin 104 measurement	CFH ZNF705G	2.77e-04	4	202	2	EFO_0801416
Disease	beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 measurement	CFH C7	2.77e-04	4	202	2	EFO_0801407
Disease	protein nov homolog measurement	CFH ENPP2	2.77e-04	4	202	2	EFO_0020685
Disease	NAD-dependent protein deacylase sirtuin-5, mitochondrial measurement	CFH ZFPM2	2.77e-04	4	202	2	EFO_0801822
Disease	trem-like transcript 4 protein measurement	IGHG1 IGHG3	2.77e-04	4	202	2	EFO_0802160
Disease	sodium/potassium-transporting ATPase subunit alpha-1 measurement	IGHG1 IGHG3	2.77e-04	4	202	2	EFO_0802077
Disease	RING finger protein 165 measurement	IGHG1 IGHG3	2.77e-04	4	202	2	EFO_0802027
Disease	event free survival time, urinary bladder cancer	MYT1L GRIN2B DCLK1	2.82e-04	19	202	3	EFO_0000482, MONDO_0001187
Disease	chronic obstructive pulmonary disease	RIN3 XKR9 ZNF362 PICALM ASAP2 MRC2 SVIL MYPN DNAH5 FRAS1 DSP PPP4R4 AFAP1 OTUD4	3.01e-04	688	202	14	EFO_0000341
Disease	aortic measurement	CFH MASP1 ENPP2 SVIL ABCC9 AFAP1 HAS2 CXADR	3.55e-04	251	202	8	EFO_0020865
Disease	otitis media (implicated_via_orthology)	ENPP1 DNAH5 TP73	4.42e-04	22	202	3	DOID:10754 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	MYT1L PHF2 DOCK8 GRIN2B ADNP	4.56e-04	93	202	5	C1535926
Disease	potassium voltage-gated channel subfamily E member 2 measurement	IGHG1 IGHG3	4.60e-04	5	202	2	EFO_0801901
Disease	protein shisa-3 homolog measurement	IGHG1 IGHG3	4.60e-04	5	202	2	EFO_0801964
Disease	insulin-like growth factor I measurement	CFH C7	4.60e-04	5	202	2	EFO_0801702
Disease	ERO1-like protein alpha measurement	CFH C7	6.87e-04	6	202	2	EFO_0801582
Disease	cytosolic non-specific dipeptidase measurement	CFH C7	6.87e-04	6	202	2	EFO_0020310
Disease	cyclin-dependent kinase 8:cyclin-c complex measurement	CFH C7	6.87e-04	6	202	2	EFO_0020297
Disease	galectin-7 measurement	CFH ZFPM2	6.87e-04	6	202	2	EFO_0022034
Disease	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 measurement	CFH C7	6.87e-04	6	202	2	EFO_0801372
Disease	carcinoembryonic antigen-related cell adhesion molecule 1 measurement	IGHG1 IGHG3	6.87e-04	6	202	2	EFO_0801456
Disease	beta-sarcoglycan measurement	IGHG1 IGHG3	6.87e-04	6	202	2	EFO_0801422
Disease	serine/threonine-protein kinase PAK 3 measurement	CFH C7	6.87e-04	6	202	2	EFO_0020728
Disease	receptor-type tyrosine-protein kinase flt3 measurement	CFH C7	6.87e-04	6	202	2	EFO_0020703
Disease	somatostatin-28 measurement	CFH ZFPM2	6.87e-04	6	202	2	EFO_0020745
Disease	protocadherin beta-4 measurement	CFH C7	6.87e-04	6	202	2	EFO_0801976
Disease	voltage-dependent calcium channel subunit alpha-2/delta-3 measurement	CFH PIGC	6.87e-04	6	202	2	EFO_0802218
Disease	zinc finger protein 276 measurement	CFH C7	6.87e-04	6	202	2	EFO_0802227
Disease	phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform measurement	CFH C7	6.87e-04	6	202	2	EFO_0020637
Disease	multiple coagulation factor deficiency protein 2 measurement	IGHG1 IGHG3	6.87e-04	6	202	2	EFO_0801810
Disease	complement C1q subcomponent measurement	IGHG1 IGHG3	6.87e-04	6	202	2	EFO_0008089
Disease	mean platelet volume	RIN3 MYO1E DOCK11 ATAD5 PFKFB4 PICALM PI4KA SVIL ANKRD28 ARID4A DOCK8 POLR2A FCHO2 ZFPM2 CRKL AFAP1 ARHGAP18	6.93e-04	1020	202	17	EFO_0004584
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	CHRNB2 ADGRL3 GRIN2B	9.13e-04	28	202	3	DOID:1094 (implicated_via_orthology)
Disease	ectonucleoside triphosphate diphosphohydrolase 3 measurement	CFH C7	9.57e-04	7	202	2	EFO_0020343
Disease	BCL-2-like protein 1 measurement	CFH C7	9.57e-04	7	202	2	EFO_0020177
Disease	regulator of G-protein signaling 8 measurement	CFH C7	9.57e-04	7	202	2	EFO_0801997
Disease	phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha measurement	CFH C7	9.57e-04	7	202	2	EFO_0801881
Disease	inducible T-cell costimulator measurement	IGHG1 IGHG3	9.57e-04	7	202	2	EFO_0021967
Disease	uroplakin-3b-like protein measurement	CFH C7	9.57e-04	7	202	2	EFO_0802204
Disease	kinesin-like protein KIF16B measurement	CFH C7	9.57e-04	7	202	2	EFO_0801747
Disease	macrophage-stimulating protein receptor measurement	CFH C7	9.57e-04	7	202	2	EFO_0020550
Disease	seasonal gut microbiome measurement	NAV2 ZFPM2 BTBD16 MYOF ARHGAP18	1.06e-03	112	202	5	EFO_0007753
Disease	Intellectual Disability	MYT1L L2HGDH CA8 CACNA1E DOCK8 FARSB GRIN2B AP4E1 SERAC1 EPB41L1	1.09e-03	447	202	10	C3714756
Disease	Malignant neoplasm of breast	EPHB4 BRIP1 ERCC3 ATP7B EFCAB13 PFKFB4 COG3 DYSF PKDREJ BMP1 OTOF KRAS ADAMTS1 USP54 ARHGEF4 GALNT5 TP73	1.22e-03	1074	202	17	C0006142
Disease	interleukin-8 measurement	MYT1L CFH UNC13C	1.23e-03	31	202	3	EFO_0004811
Disease	Ovarian Mucinous Adenocarcinoma	MATK CDKL2 HCK	1.23e-03	31	202	3	C1335167
Disease	desmoglein-1 measurement	CFH C7	1.27e-03	8	202	2	EFO_0020321
Disease	cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement	CFH C7	1.27e-03	8	202	2	EFO_0801513
Disease	alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement	CFH C7	1.27e-03	8	202	2	EFO_0801373
Disease	chromobox protein homolog 5 measurement	CFH C7	1.27e-03	8	202	2	EFO_0020258
Disease	tumor necrosis factor receptor superfamily member 3 measurement	CFH C7	1.27e-03	8	202	2	EFO_0020813
Disease	stabilin-2 measurement	CFH C7	1.27e-03	8	202	2	EFO_0020752
Disease	programmed cell death 1 ligand 2 measurement	CFH DHX36	1.27e-03	8	202	2	EFO_0008268
Disease	hepatitis A virus cellular receptor 2 measurement	CFH NOMO3	1.27e-03	8	202	2	EFO_0008151
Disease	zinc-alpha-2-glycoprotein measurement	CFH C7	1.27e-03	8	202	2	EFO_0802228
Disease	opioid-binding protein/cell adhesion molecule measurement	CFH C7	1.27e-03	8	202	2	EFO_0020618
Disease	kallikrein-6 measurement	CFH C7	1.27e-03	8	202	2	EFO_0801739
Disease	pulse pressure measurement	EPHB4 CFH RIN3 MYO1E PDGFRA ENPP2 EFCAB13 DYSF S100A8 ASAP2 MRC2 MYPN ADAMTS15 ABCC9 HEATR5A DENND4C ZFPM2 AFAP1 CFAP69 XRCC6	1.47e-03	1392	202	20	EFO_0005763
Disease	TNF-related apoptosis-inducing ligand measurement	CFH SIPA1L3 CHST9 KIF26B	1.52e-03	72	202	4	EFO_0008300
Disease	primary dental caries	CFH CHST9 GRIN2B	1.62e-03	34	202	3	EFO_0600095
Disease	complement C1q and tumor necrosis factor-related protein 9A measurement	CFH C7	1.63e-03	9	202	2	EFO_0803293
Disease	epididymal-specific lipocalin-10 measurement	CFH C7	1.63e-03	9	202	2	EFO_0801576
Disease	dickkopf-like protein 1 measurement	CFH C7	1.63e-03	9	202	2	EFO_0020324
Disease	cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement	CFH C7	1.63e-03	9	202	2	EFO_0801514
Disease	ectonucleoside triphosphate diphosphohydrolase 1 measurement	CFH C7	1.63e-03	9	202	2	EFO_0020342
Disease	cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement	CFH C7	1.63e-03	9	202	2	EFO_0020296
Disease	cellular retinoic acid-binding protein 1 measurement	CFH C7	1.63e-03	9	202	2	EFO_0801463
Disease	apolipoprotein D measurement	CFH C7	1.63e-03	9	202	2	EFO_0020156
Disease	oxysterols receptor LXR-beta measurement	CFH C7	1.63e-03	9	202	2	EFO_0801865
Disease	2-hydroxyglutaric acid measurement	L2HGDH ADAMTS15	1.63e-03	9	202	2	EFO_0010446
Disease	complement component C8 measurement	CFH C7	1.63e-03	9	202	2	EFO_0008094
Disease	synaptotagmin-11 measurement	CFH ZFPM2	1.63e-03	9	202	2	EFO_0802108
Disease	mast cell-expressed membrane protein 1 measurement	CFH C7	1.63e-03	9	202	2	EFO_0801787
Disease	interleukin-34 measurement	CFH C7	1.63e-03	9	202	2	EFO_0020505
Disease	kallikrein-14 measurement	CFH C7	1.63e-03	9	202	2	EFO_0020513
Disease	leucine-rich repeat serine/threonine-protein kinase 2 measurement	CFH C7	1.63e-03	9	202	2	EFO_0021876
Disease	RNA-binding protein 24 measurement	CFH C7	1.63e-03	9	202	2	EFO_0802030
Disease	heterogeneous nuclear ribonucleoprotein q measurement	CFH C7	1.63e-03	9	202	2	EFO_0020443
Disease	DNA-directed RNA polymerases I and III subunit RPAC1 measurement	CFH C7	2.02e-03	10	202	2	EFO_0801535
Disease	DNA repair protein rad51 homolog 1 measurement	CFH C7	2.02e-03	10	202	2	EFO_0020330
Disease	Secreted frizzled-related protein 3 measurement	CFH C7	2.02e-03	10	202	2	EFO_0008277
Disease	serine/threonine-protein kinase 16 measurement	CFH C7	2.02e-03	10	202	2	EFO_0020724
Disease	tropomyosin beta chain measurement	CFH C7	2.02e-03	10	202	2	EFO_0020787
Disease	multimerin-2 measurement	CFH IGHG1	2.02e-03	10	202	2	EFO_0801809
Disease	interleukin-37 measurement	CFH C7	2.02e-03	10	202	2	EFO_0020506

Protein segments in the cluster

Peptide	Gene	Start	Entry
KLVKLGAAKCTSALP	nan	581	A8MVM7
AAVPYKKDVGKTLCP	ADNP	611	Q9H2P0
CKTITKYLSPLGKTR	ATAD5	36	Q96QE3
LICALKNPGKYKSVS	ESD	156	P10768
KIPLKGTDLYGNCFK	AGBL3	746	Q8NEM8
VAVLKKTCATKPAFL	ARHGEF10	526	O15013
CPEGRQLDIKKSSYK	EIF2D	301	P41214
KNGDYLCVKVDRTPK	EIF3B	521	P55884
EPCLTGTKVKVKYGR	ARID4A	571	P29374
GLGKRCPSKVAYKRL	CACNA1E	1776	Q15878
QKKFYSKGLRLECPI	NT5C1A	261	Q9BXI3
LKPSTIKKFYEAGCK	BTBD16	206	Q32M84
KKKIANALCILLYPG	ALG6	141	Q9Y672
VVLSSLQLKCYKKPD	ATP7B	1366	P35670
AKKYIVPALAKACVN	BTBD6	216	Q96KE9
KLSHPKLVKFYGVCS	BMX	466	P51813
YDDVPCINGSLKGKK	AFAP1	501	Q8N556
PKYAKELKNTCKAVL	GPR18	126	Q14330
YFKGADPTKCIVKIT	FCHO2	556	Q0JRZ9
YVPKGKTKTSRDLAC	APBB1IP	341	Q7Z5R6
YKVEQKVFLCPGLLK	ADGRL3	126	Q9HAR2
LDGFLLTPVQKICKY	ARHGEF4	416	Q9NR80
VCGPLAYKKLVKKFR	CD5	396	P06127
GAEVTCKDKKSYTPL	ANKRD28	196	O15084
YSLVKKILKKGLCDP	ANKRD66	21	B4E2M5
KILKKGLCDPNYKDV	ANKRD66	26	B4E2M5
SSDGRYVKENCKPLK	CLK3	566	P49761
HVKAYIKPGQKVGIC	ABCC9	1331	O60706
YLLLKKLVKENKCPC	ARL13A	146	Q5H913
LIKAGKKCLAVYQPE	CCN4	266	O95388
QYKVGEVLKFSCKPG	CFH	586	P08603
KPIYKSQACPLSEKR	BVES-AS1	21	Q5T3Y7
SKGDIAQARKLYKCP	BMP1	306	P13497
KEKPVCGTTYKVLKE	CAPRIN1	221	Q14444
KGNKRPYQKDCVLII	EAF1	76	Q96JC9
KKSSPNCKLTVYLGK	ARRB2	11	P32121
KYSGVSPRDKCKLIC	ADAMTS15	606	Q8TE58
KAAKCIGKFVLSPKI	AP4E1	336	Q9UPM8
KKCGQKLVSRALGYI	NWD2	651	Q9ULI1
YRLKKISKEEKTPGC	KRAS	166	P01116
DAFCKPQLVKKSYGV	GPRC5A	281	Q8NFJ5
KGVNRFCLSKPGVYK	NOMO3	621	P69849
KLGLYRKLVAKDGSC	OTUD4	31	Q01804
IPKYAGVSPKDRCKL	ADAMTS1	646	Q9UHI8
LKKCYQTFPLDRKKG	INSYN2A	111	Q6ZSG2
LICKEPTGLKYEKAK	PAXIP1	746	Q6ZW49
PYICEATVKGKKFQT	PDGFRA	186	P16234
TCQVPKTLYKGVPLK	ANOS1	171	P23352
SPQKIAKKYKSAICR	EPB41L1	86	Q9H4G0
KGVNRFCLSKPGVYK	NOMO2	621	Q5JPE7
PTVCQYCKKLLKGLF	PRKD1	281	Q15139
IIKLSALPKYGCIEN	FRAS1	1871	Q86XX4
IKINQKCSYIPKCGK	KCNMB2	136	Q9Y691
YSKDKGAICTKLVRP	MATK	196	P42679
TGQKCALKLLYDSPK	MAPKAPK3	66	Q16644
EKYKPLITGEKKVQC	NEK1	841	Q96PY6
APGKKESCVAIKTLK	EPHB4	636	P54760
KALILGIYKQGLKCR	RASGRP2	516	Q7LDG7
PRAKKLEKLGVYSAC	KAT2B	86	Q92831
IYYKPESLKAKLCVQ	L2HGDH	101	Q9H9P8
LLLKPEKCYLVKGNI	L2HGDH	286	Q9H9P8
GLKLTFCPKKIYSVT	FNDC7	701	Q5VTL7
ATKLKPKRVKALYNC	ASAP2	941	O43150
RGKKYGVNEVCSPTK	KIF26B	16	Q2KJY2
CLYPGAIKKAKGADQ	ZFPM2	966	Q8WW38
CGSIEPFKKLEYTKN	DCLK1	131	O15075
LRGQPSCTKAYKKET	CD200R1L	71	Q6Q8B3
EPLLGQKIKPKCSIY	EFHC2	46	Q5JST6
YLCGAISLAPKAQIK	PDCD1	121	Q15116
LKLTPVAYGCKVESI	PFKFB4	421	Q16877
EKPAVCYQAITKKLK	GLYR1	226	Q49A26
KGVNRFCLSKPGVYK	NOMO1	621	Q15155
APYLAKFKVKRCGVS	PI4KA	1801	P42356
CSIALPYVCKKKPNA	MRC2	351	Q9UBG0
LASKACIPYLKKSKV	HSDL2	131	Q6YN16
CIPYLKKSKVAHILN	HSDL2	136	Q6YN16
IILRGQPSCTKAYKK	CD200R1	76	Q8TD46
LLPVISKLKKCGTYT	ENPP1	231	P22413
TNIKKPIKCSAPKYI	MOB1B	101	Q7L9L4
GAEVTCKDKKGYTPL	ANKRD44	196	Q8N8A2
CKALAPEYAKAAGKL	P4HB	56	P07237
KAIQKRVPCAYDKTA	CRKL	241	P46109
LSYLIVSLPKCKNKA	OOSP4A	166	A0A2R8YFL7
VSLGKKLKACPYYTA	BRIP1	341	Q9BX63
PLLKKLYCQIAKTCP	TP73	146	O15350
PIQGYRVDEKTKKCS	CDKL2	436	Q92772
GKCPKNKLFKVYIEL	CRNKL1	601	Q9BZJ0
TKSIKKQVKIGSPYC	EPB41L5	101	Q9HCM4
YKKGNDGLCQKLSVP	HCK	226	P08631
TKLAAVVCLGSLYKK	HEATR5A	111	Q86XA9
YTGKIGNVCKKLSSP	IFIT5	116	Q13325
GSKEVPGELIKYLKC	DOCK11	841	Q5JSL3
RCVKPEVKVKIAALY	DOCK8	1201	Q8NF50
FKGSKKPYLKECILI	EAF2	76	Q96CJ1
GIIKTLLRCPSKKKY	CCR3	221	P51677
PIYLLKFKQCLSKAL	COG3	246	Q96JB2
LPNKCSGKTQPKYLK	GAS2L3	461	Q86XJ1
KILKVAACDPVKPYQ	GALNT5	916	Q7Z7M9
IKAVICAGLYPKVAK	DHX36	831	Q9H2U1
KAKGETAYLPCKFTL	CXADR	31	P78310
AKILTCPKTKLKISY	DSP	2771	P15924
CPKTKLKISYKDAIN	DSP	2776	P15924
LQDIQYKGKSKTIPC	CA8	186	P35219
ELVKEVPCASVKKLY	C7	426	P10643
KCLQSVKRLTYPGIK	HAS2	101	Q92819
PKSVCKAPELLAKYC	CUL2	381	Q13617
KPCKNLLSTLKKLYP	DENND4C	511	Q5VZ89
DVCKKLLGKYPNVDA	UGCG	96	Q16739
VNIVEKYGVIPKKCF	BLMH	151	Q13867
ILTIPKAAGKFYLIC	EFCAB13	896	Q8IY85
IKSFCKILGPLSYSK	LUM	291	P51884
HSTCQKAYAPLKKKV	MASP1	611	P48740
VGQYIFVKCPKVSKL	CYBB	321	P04839
TCDVKFKNYLIPKGT	CYP2C18	371	P33260
EYKCKVSNKALPAPI	IGHG1	201	P01857
GKEYKCKVSNKALPA	IGHG3	246	P01860
AQCGKAFPKAYLLKK	E4F1	466	Q66K89
IKLCTVSYGKVKLVL	ERCC3	156	P19447
AYDIIKLCGLPFLKK	CFAP69	111	A5D8W1
KIICDKYKTGVIDGP	DIPK1A	61	Q5T7M9
IKEIPGIGYKTAKCL	POLI	261	Q9UNA4
KKLKTILECRGLGYS	RNF103	46	O00237
NGKCDPYIKISIGKK	DYSF	1596	O75923
YKCLAKAKAKSPLDQ	IFT140	1311	Q96RY7
FKKVLISYELKACNP	IZUMO2	121	Q6UXV1
KKKSKEQPAACVEGY	PPRC1	461	Q5VV67
AKYDPKAIIANLTCK	ENPP2	401	Q13822
KSLTGYLEKKRLCFP	DNAH5	1701	Q8TE73
KTGACRVEYKKELLP	LRRC74B	366	Q6ZQY2
PAQICLKGKVHIFKY	LRCH2	286	Q5VUJ6
KDCAKVKTLFLKLPG	OTOF	881	Q9HC10
DTIKINGCLKGKLIY	NXPE1	336	Q8N323
SALYKCVLKPLKEAI	RIN3	681	Q8TB24
CGLSKNPYLSVKQKV	MRPS31	356	Q92665
TVKAICIPEGAKYLK	DARS2	366	Q6PI48
SKGCVTITKKYIKIP	SENP7	536	Q9BQF6
ICKPKKKDAFLYQRT	SERAC1	626	Q96JX3
KLLETECPQYIRKKG	S100A8	36	P05109
ALLAKPKVTKYCLIC	PHF2	226	O75151
CYLLPKVKSTLKIPA	PPP4R4	626	Q6NUP7
DYPIKGLVKTISCKP	SAXO1	176	Q8IYX7
TVLQYCKGKNLKKPA	SVIL	2086	O95425
LKKYVSVCEGPLKEQ	RIMOC1	261	A6NDU8
PLFKCNDIGQKIYSK	RETREG1	231	Q9H6L5
DSLKLCLVGSLKKFY	PIWIL2	786	Q8TC59
TNIKKPIKCSAPKYI	MOB1A	101	Q9H8S9
ILLSGFRTNKPKYCK	PKDREJ	1631	Q9NTG1
PCYLKLGSKVEVSKT	NAV2	36	Q8IVL1
LIGEKVCLKGFTKYA	SIPA1L3	656	O60292
YKLCKVRKITVGTKG	RPS4Y2	121	Q8TD47
KAYDLFCGLQKGPKL	SLC5A4	601	Q9NY91
ILGIYKCTFTHKKLG	SCYL2	546	Q6P3W7
YADRALKKCPDQGKI	VPS8	556	Q8N3P4
CLGSSLKVLKKYPRL	SIRT7	266	Q9NRC8
CALEPIVKKLAGYLT	NPRL2	96	Q8WTW4
LQKKLKACTPRSYVG	PIGC	216	Q92535
AKAPYLAKFKVKRCG	PI4KAP2	266	A4QPH2
IKFKPLNKTKEYTAC	FARSB	181	Q9NSD9
LPPAIYKSACKIEVK	CHRNB2	146	P17787
PKSQKCVAYKFRLVV	CHRM5	371	P08912
LKPSDEGRYTCKVKN	CLMP	101	Q9H6B4
GKAIIKKYRPNACEE	CHST9	306	Q7L1S5
KSVLYLPGDFVCKKG	CNGB3	541	Q9NQW8
LKAFGYVEIPCVAKK	PPCDC	156	Q96CD2
AGKSLCYQLPALLAK	RECQL5	56	O94762
GPKKKHLDYLIQCTN	PICALM	36	Q13492
KTLLGTKLEAKYLCS	TRAF2	21	Q12933
KGKVIKDSVTLLPCF	PLPPR4	56	Q7Z2D5
LKEACRAYGLKSGLK	XRCC6	581	P12956
QKICSIALVGKYTKL	CTPS2	296	Q9NRF8
KSKYCLKINRPIGDA	ZBTB14	141	O43829
DGCIYAIKRSKKPLA	WEE1	321	P30291
KKPYVSKQCGKSLRN	ZNF705A	141	Q6ZN79
VKAEKPLKSLDFCYG	UNC80	2321	Q8N2C7
NVCGKKFRKYPSLLK	ZNF287	371	Q9HBT7
FKSLILPYIHKLCKG	UNC13C	6	Q8NB66
LKCVKALKGLYGNRD	STAG3	361	Q9UJ98
VYKKLCLCAGAKPKL	PYROXD1	106	Q8WU10
IVKLCGYPLCQKKLG	RPAP2	96	Q8IXW5
APKGASDAKLCALYK	MEX3A	106	A1L020
LGKAAKYKLAALPVA	STX17	221	P56962
QPKKRLTHVYDLCKG	POLR2A	136	P24928
KICQKTVKRYDVGAP	TMEM115	251	Q12893
KVHLKVPTGEKLYVC	ZNF585B	146	Q52M93
VYKPVDLSKVTSKCG	MAPT	626	P10636
CTKAVELNPKYVKAL	TOMM70	176	O94826
KQKKIFTIQGCYPVI	TTLL3	16	Q9Y4R7
KKPYVSKQCGKSLRN	ZNF705G	141	A8MUZ8
AVKIKTKDSGLFCVP	ARHGAP18	311	Q8N392
LKNSKFLKVCLPAYV	ZNFX1	211	Q9P2E3
KTEPSLRCGLQYQKK	TIMM21	36	Q9BVV7
SVGYCITKPKVISKL	ZNF658	46	Q5TYW1
YKKTKQLPVLGKCCE	YY1AP1	341	Q9H869
FYKSLLDICKKVPAI	WASHC4	336	Q2M389
LQLRKGYKTVGDCKL	ZNF429	111	Q86V71
KIHTKQKPYKCSDLG	ZNF484	796	Q5JVG2
AKEGKTYRCKVCPLT	ZNF362	221	Q5T0B9
IKNPVKTCDKVYSLI	PPIP5K2	656	O43314
KLEIAKGYCTPLVRK	PPIP5K2	771	O43314
QGVKAKSSLLIYKCP	ZDHHC11B	311	P0C7U3
TILCEYKPDGKVLKN	ZNF382	131	Q96SR6
VGSKKYLVAANLKKP	TOPBP1	151	Q92547
LGPALKLCYHIDKLK	SCML4	396	Q8N228
LLVSYLAVKKQKSCP	ZP4	521	Q12836
LEAVPKKLCGYLSKF	TBC1D2	41	Q9BYX2
PDKKLLNGLCPKITY	XKR9	191	Q5GH70
YIKVQKARGLDPKTC	ZMAT1	311	Q5H9K5
KDVVTKCIKGHYQPL	USP54	331	Q70EL1
CPYTAKQKGILKRHI	ZBTB8B	346	Q8NAP8
LTPKCLYLIGREKVK	MYO1E	786	Q12965
NGLCDPYIKITLGKK	MYOF	1571	Q9NZM1
TGYACLLIQPAKKSD	MYPN	1226	Q86TC9
EICKPKYLNKTSVRP	MYSM1	421	Q5VVJ2
KYLNKTSVRPGLKNC	MYSM1	426	Q5VVJ2
SVYGCPLAKKRKTQD	MYT1L	51	Q9UL68
KKLQSPIILLYCTKE	GRIN2B	221	Q13224